| 13623 |
Leronlimab (Pro 140) Cliff Notes What is it?  (39) |
trding |
12/24/2019 8:09:27 PM |
| 112006 |
Leronlimab - Disease List (currently 90) (updated (39) |
ohm20 |
12/09/2021 8:15:12 AM |
| 144440 |
Leronlimab Regulator List (a work in progress) = (19) |
ohm20 |
06/12/2024 7:33:56 PM |
| 145805 |
Here's some basics on the science - Leronlimab (50) |
ohm20 |
08/21/2024 12:48:53 PM |
|
147827 |
Doctors that work in institutions that have used (20) |
ohm20 |
11/05/2024 8:46:49 AM |
|
147826 |
Do you believe $.11-.12 is a fair and reasonable (28) |
ohm20 |
11/05/2024 8:45:15 AM |
|
147825 |
New SAB member: Clinton Yam, MD, MS Dr. Clinton (19) |
My69z |
11/05/2024 8:39:28 AM |
|
147824 |
So many companies get a price pop on good data, (5) |
Evil Rabbit |
11/05/2024 8:28:27 AM |
|
147821 |
Figgs, Since you don't like 18 months, what time (14) |
SamaGong |
11/05/2024 7:18:27 AM |
|
147820 |
Surrogate reads like anecdotal is back in play. (4) |
mfglola |
11/05/2024 6:59:00 AM |
|
147819 |
Agreed. It made it to $10.01 on a whole lot less! (2) |
Boatbuilder |
11/05/2024 5:14:31 AM |
|
147818 |
" Even in that small of a trial we should see (1) |
My69z |
11/05/2024 2:39:51 AM |
|
147817 |
Saying it's not unmet need ? Leronlimab would (11) |
ohm20 |
11/05/2024 1:38:38 AM |
|
147816 |
Inflammation ph2? Have we received FDA trial (2) |
chazzledazzle |
11/05/2024 1:25:04 AM |
|
147815 |
Article on GLP-1 side effects leading to (1) |
Drano |
11/05/2024 1:16:41 AM |
|
147814 |
Surrogate reads like anecdotal is back in play. " (1) |
My69z |
11/05/2024 12:06:38 AM |
|
147813 |
I do not need to see anything but totally (18) |
Figgs |
11/04/2024 11:50:54 PM |
|
147812 |
Saying it's not unmet need ? There are many unmet (3) |
My69z |
11/04/2024 11:30:40 PM |
|
147811 |
A surrogate endpoint.... The FDA instituted its (3) |
ohm20 |
11/04/2024 11:02:28 PM |
|
147810 |
For the Alzheimer's trial you mentioned that (8) |
ohm20 |
11/04/2024 10:47:37 PM |
|
147809 |
A surrogate endpoint.... The FDA instituted its (4) |
My69z |
11/04/2024 9:45:02 PM |
|
147808 |
I was wondering about glioblastoma too...that (1) |
cardamine |
11/04/2024 8:59:22 PM |
|
147807 |
While the FDA does not typically grant (3) |
My69z |
11/04/2024 8:27:47 PM |
|
147806 |
For the Alzheimer's trial you mentioned that (4) |
Ramjet |
11/04/2024 7:56:56 PM |
|
147805 |
On that there was a post showing a small trial of |
My69z |
11/04/2024 7:44:32 PM |
|
147804 |
Those numbers suggest an average of 155 patients (6) |
ohm20 |
11/04/2024 7:41:06 PM |
|
147803 |
If I remember right, others also mentioned great (5) |
ohm20 |
11/04/2024 7:37:50 PM |
|
147802 |
I might be off target here...it certainly (9) |
ohm20 |
11/04/2024 7:32:30 PM |
|
147801 |
I haven't seen any direct results for (6) |
ohm20 |
11/04/2024 7:26:29 PM |
|
147800 |
As far as Oaempic etc. side effects eventually (3) |
Drano |
11/04/2024 7:15:41 PM |
|
147799 |
1 thing I noticed a little while ago, it seems (2) |
My69z |
11/04/2024 7:12:50 PM |
|
147798 |
Those numbers suggest an average of 155 patients (1) |
sean007 |
11/04/2024 7:08:18 PM |
|
147797 |
Don't forget Aug. 2024: " This open label, (5) |
My69z |
11/04/2024 6:58:36 PM |
|
147796 |
I might be off target here...it certainly (2) |
sean007 |
11/04/2024 6:58:34 PM |
|
147795 |
Interesting, thanks.. I've read that Tirzepatide (1) |
sunray3 |
11/04/2024 6:42:44 PM |
|
147794 |
Interested or invested?...How you comport (1) |
sean007 |
11/04/2024 6:39:53 PM |
|
147793 |
Syneos oncology since 2019. Click on View our (7) |
My69z |
11/04/2024 6:04:05 PM |
|
147792 |
Typically, how long are these trials? weeks, (8) |
ohm20 |
11/04/2024 5:59:15 PM |
|
147791 |
Ohm Thanks for the reply. That helps me (2) |
nelsonsjavaheads |
11/04/2024 5:44:51 PM |
|
147790 |
Sometimes being around a while means you have (16) |
docj |
11/04/2024 5:34:01 PM |
|
147789 |
Can you explain in layman's terms what going to (23) |
ohm20 |
11/04/2024 5:20:21 PM |
|
147788 |
There may be breakout news What might this (14) |
ohm20 |
11/04/2024 4:58:18 PM |
|
147787 |
Kat It seems you have been in the industry and (3) |
nelsonsjavaheads |
11/04/2024 4:56:55 PM |
|
147786 |
He's/She's a Short...dressed with DOC handle and (13) |
ohm20 |
11/04/2024 4:55:39 PM |
|
147785 |
While these drugs (GLP-1 agonists) do have their (12) |
ohm20 |
11/04/2024 4:53:31 PM |
|
147784 |
Yea & very likely the norm across human trials. |
My69z |
11/04/2024 4:36:26 PM |
|
147783 |
There may be breakout news What might this |
mountaineer |
11/04/2024 4:22:28 PM |
|
147782 |
My hand is up. (1) |
sean007 |
11/04/2024 4:04:36 PM |
|
147781 |
He's/She's a Short...dressed with DOC handle and (2) |
sean007 |
11/04/2024 4:02:11 PM |
|
147780 |
https://tech.snmjournals.org/content/52/1/3 (1) |
sunray3 |
11/04/2024 3:45:40 PM |
|
147779 |
A very realistic perspective. I'm personally (5) |
docj |
11/04/2024 3:43:59 PM |
|
147778 |
Why not the next 3-4 months?? I would expect (11) |
ohm20 |
11/04/2024 3:35:56 PM |
|
147777 |
That would be interesting. Looking forward to the (2) |
docj |
11/04/2024 3:13:40 PM |
|
147776 |
CRC -- my bet is interim look. (7) |
My69z |
11/04/2024 3:06:47 PM |
